|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang WQ, Fu FF, Li YX, Wang WB, Wang HH,
Jiang HP and Teng LS: Molecular biomarkers of colorectal cancer:
Prognostic and predictive tools for clinical practice. J Zhejiang
Univ Sci B. 13:663–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aakif M, Balfe P, Elfaedy O, Awan FN,
Pretorius F, Silvio L, Castinera C and Mustafa H: Study on
colorectal cancer presentation, treatment and follow-up. Int J
Colorectal Dis. 31:1361–1363. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du B and Shim JS: Targeting
Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance
in Cancer. Molecules. 21(pii): E9652016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Phillips TA, Howell A, Grieve RJ and
Welling PG: Pharmacokinetics of oral and intravenous fluorouracil
in humans. J Pharm Sci. 69:1428–1431. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Juchum M, Günther M and Laufer SA:
Fighting cancer drug resistance: Opportunities and challenges for
mutation-specific EGFR inhibitors. Drug Resist Update. 20:12–28.
2015. View Article : Google Scholar
|
|
8
|
Kim JK, Kang KA, Piao MJ, Ryu YS, Han X,
Fernando PM, Oh MC, Park JE, Shilnikova K, Boo SJ, et al:
Endoplasmic reticulum stress induces 5-fluorouracil resistance in
human colon cancer cells. Environ Toxicol Pharmacol. 44:128–133.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen A, Chen H, Chen Y, Lin J, Lin W, Liu
L, Sferra TJ and Peng J: Pien Tze Huang overcomes multidrug
resistance and epithelial-mesenchymal transition in human
colorectal carcinoma cells via suppression of TGF-β pathway. Evid
Based Complement Alternat Med. 2014:6794362014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pecina-Slaus N, Cicvara-Pecina T and Kafka
A: Epithelial-to-mesenchymal transition: Possible role in
meningiomas. Front Biosci (Elite Ed). 4:889–896. 2012.PubMed/NCBI
|
|
11
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roberts AB: Molecular and cell biology of
TGF-beta. Miner Electrolyte Metab. 24:111–119. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Derynck R, Akhurst RJ and Balmain A:
TGF-beta signaling in tumor suppression and cancer progression. Nat
Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Trapani JA: The dual adverse effects of
TGF-beta secretion on tumor progression. Cancer Cell. 8:349–350.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Heldin CH, Vanlandewijck M and Moustakas
A: Regulation of EMT by TGFβ in cancer. FEBS Lett. 586:1959–1970.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brunen D, Willems SM, Kellner U, Midgley
R, Simon I and Bernards R: TGF-β: An emerging player in drug
resistance. Cell Cycle. 12:2960–2968. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moustakas A and Heldin P: TGFβ and
matrix-regulated epithelial to mesenchymal transition. Biochim
Biophys Acta. 1840:2621–2634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song LR: Zhonghuabencao. Shanghai Science
and Technology Press; Shanghai: pp. 4331999
|
|
21
|
Yang JJ, Hsu HY, Ho YH and Lin CC:
Comparative study on the immunocompetent activity of three
different kinds of Peh-Hue-Juwa-Chi-Cao, Hedyotis diffusa, H.
corymbosa and Mollugo pentaphylla after sublethal whole body
x-irradiation. Phytother Res. 11:428–432. 1997. View Article : Google Scholar
|
|
22
|
Li R, Zhao HR and Lin YM: Anti-tumor
effect and protective effect on chemotherapeutic damage of water
soluble extracts from Hedyotis diffusa. J Chin Pharmaceu Sci.
11:54–58. 2002.
|
|
23
|
Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan
Y, Zeng J, Xu W, Shen A, Hong Z and Peng J: Hedyotis diffusa Willd
inhibits colorectal cancer growth in vivo via inhibition of STAT3
signaling pathway. Int J Mol Sci. 13:6117–6128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin J, Wei L, Shen A, Cai Q, Xu W, Li H,
Zhan Y, Hong Z and Peng J: Hedyotis diffusa Willd extract
suppresses Sonic hedgehog signaling leading to the inhibition of
colorectal cancer angiogenesis. Int J Oncol. 42:651–656. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin J, Chen Y, Wei L, Chen X, Xu W, Hong
Z, Sferra TJ and Peng J: Hedyotis diffusa Willd extract induces
apoptosis via activation of the mitochondrion-dependent pathway in
human colon carcinoma cells. Int J Oncol. 37:1331–1338.
2010.PubMed/NCBI
|
|
26
|
Lin J, Wei L, Xu W, Hong Z, Liu X and Peng
J: Effect of Hedyotis diffusa Willd extract on tumor angiogenesis.
Mol Med Rep. 4:1283–1288. 2011.PubMed/NCBI
|
|
27
|
Lin M, Lin J, Wei L, Xu W, Hong Z, Cai Q,
Peng J and Zhu D: Hedyotis diffusa Willd extract inhibits HT-29
cell proliferation via cell cycle arrest. Exp Ther Med. 4:307–310.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Q, Wang X, Shen A, Zhang Y, Chen Y,
Sferra T, Lin J and Peng J: Hedyotis diffusa Willd overcomes
5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU
cells by downregulating the expression of P-glycoprotein and
ATP-binding casette subfamily G member 2. Exp Ther Med.
10:1845–1850. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moustakas A and Heldin CH: The regulation
of TGFbeta signal transduction. Development. 136:3699–3714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zi Z, Chapnick DA and Liu X: Dynamics of
TGF-β/SMAD signaling. FEBS Lett. 586:1921–1928. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Massagué J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Massagué J and Wotton D: Transcriptional
control by the TGF-beta/Smad signaling system. EMBO J.
19:1745–1754. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor Snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tanaka T, Goto K and Iino M: Sec8
modulates TGF-β induced EMT by controlling N-cadherin via
regulation of Smad3/4. Cell Signal. 29:115–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
